Treatment of Canine Leptospirosis: From First Dose to Critical Care

Leptospirosis is one of the few infectious diseases in small animal practice where waiting for diagnostic confirmation can directly worsen outcomes. The disease progresses rapidly, with the potential to cause acute kidney injury (AKI), hepatic dysfunction, and life-threatening pulmonary complications. Because of this, treatment should be initiated as soon as clinical suspicion is high, regardless of pending test results. 

The dual goals of therapy are clear: eliminate the organism and support affected organ systems until recovery. 

Antimicrobial Therapy: The Backbone of Management 

The traditional and widely accepted approach involves a two-phase antimicrobial strategy. Initially, treatment focuses on controlling bacteremia using intravenous penicillin derivatives such as ampicillin, amoxicillin, or penicillin G. This is particularly important in dogs presenting with vomiting or gastrointestinal signs, where oral medications may not be tolerated¹. 

Once the patient stabilizes, therapy is transitioned to oral doxycycline, administered at 5 mg/kg every 12 hours for two weeks. Doxycycline plays a crucial role in eliminating leptospires from the renal tubules and preventing chronic shedding¹. 

A practical point to remember is that antimicrobial therapy should never be delayed. Even in uncertain cases, early treatment is justified due to the disease’s zoonotic potential and severity. Dose adjustments, particularly for penicillins, may be required in dogs with severe AKI to prevent drug accumulation^1,2. 

Fluid Therapy: Balancing Correction and Caution 

Fluid therapy remains central to managing leptospirosis-associated AKI, but it requires careful balance. While aggressive fluid administration is often needed to correct dehydration and maintain renal perfusion, overhydration can be equally dangerous, especially in dogs with pulmonary involvement³. 

Dogs with non-oliguric AKI may become markedly polyuric and require high fluid rates to maintain hydration. Conversely, oliguric or anuric patients are at high risk of fluid overload, necessitating close monitoring of body weight, urine output, and respiratory status. 

Managing Multisystem Complications 

Leptospirosis is not just a renal disease; it is a multisystem disorder, and supportive care must reflect this complexity. Gastrointestinal signs such as vomiting require antiemetics and gastroprotectants, while electrolyte imbalances need prompt correction¹. 

Pain management is best achieved using opioids, as non-steroidal anti-inflammatory drugs are contraindicated due to renal compromise. Nutritional support is another critical yet often overlooked component. Dogs recovering from leptospirosis require highly digestible, protein-adequate diets to prevent catabolism and support healing. 

Hepatic involvement may prompt consideration of antioxidant therapies, although evidence supporting their use in leptospirosis remains limited. Similarly, coagulopathies should be managed based on individual patient assessment, with plasma transfusions considered in severe cases. 

When to Consider Advanced Interventions 

Extracorporeal kidney support therapy (EKST), including hemodialysis, has become increasingly important in managing severe leptospirosis. It is particularly indicated in dogs with refractory hyperkalemia, severe azotemia, or fluid overload. 

Early initiation of dialysis, rather than waiting for failure of conservative management, has been associated with improved outcomes. Studies report survival rates exceeding 80% in dogs with severe AKI treated with EKST¹. 

For clinicians, the key decision is timely referral. Dogs in advanced stages of AKI (IRIS Grade 4) should be considered candidates for early transfer to facilities offering dialysis. 

Monitoring and Adjusting Treatment 

Successful management requires continuous reassessment. Serum biochemistry should ideally be monitored every 24 hours during hospitalization, with attention to renal parameters, electrolytes, and liver enzymes. Urine output, body weight, and hydration status should be tracked closely to guide fluid therapy. 

Improvement is often gradual. Renal parameters typically normalize over 10 to 14 days, although full recovery may take weeks to months. Persistent abnormalities should prompt evaluation for complications or chronic kidney disease¹. 

Clinical Takeaway 

The treatment of leptospirosis is not defined by a single protocol but by timely intervention, careful monitoring, and adaptability. Early antimicrobial therapy, judicious fluid management, and recognition of when to escalate care are the pillars of successful outcomes. 

In practice, the difference between survival and mortality often lies not in the availability of advanced therapies, but in how early and effectively initial management is implemented. 

Reference 

1. Sykes JE, Francey T, Schuller S, Stoddard RA, Cowgill LD, Moore GE. Updated ACVIM consensus statement on leptospirosis in dogs. Journal of veterinary internal medicine. 2023 Nov;37(6):1966-82. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jvim.16903?utm_source=consensus 

2. Monaghan KN, Labato MA, Papich MG. Ampicillin pharmacokinetics in azotemic and healthy dogs. Journal of veterinary internal medicine. 2021 Mar;35(2):987-92. https://academic.oup.com/jvim/article-pdf/35/2/987/66652403/jvim16026.pdf 
3. Langston C, Gordon D. Effects of IV fluids in dogs and cats with kidney failure. Frontiers in veterinary science. 2021 Apr 20;8:659960. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2021.659960/full